FDA DEVICE FACTS
Straumann® BLC Implants - Indication Widening
Institut Straumann AG
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Straumann® dental implants for use in the pterygoid region are indicated in cases of severe jaw resorption for the functional and esthetic oral rehabilitation of the upper jaw in edentulous or partially edentulous patients. This indication is limited to Straumann® BLC bone-level implants with a length of 18 mm and a diameter of 3.75 mm (RB platform). Implants anchored in the pterygoid region shall be placed using a free-hand surgical technique and restored only in splinted applications utilizing at least two implants in combination with screw retained abutments. Prescription Use.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。